These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 16888804)

  • 1. Cytokines and hematopoietic stem cell mobilization.
    Nervi B; Link DC; DiPersio JF
    J Cell Biochem; 2006 Oct; 99(3):690-705. PubMed ID: 16888804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma.
    Steinberg M; Silva M
    Clin Ther; 2010 May; 32(5):821-43. PubMed ID: 20685493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of VLA4 and CXCR4 Antagonists for the Mobilization of Hematopoietic Stem and Progenitor Cells.
    Ruminski PG; Rettig MP; DiPersio JF
    Biomolecules; 2024 Aug; 14(8):. PubMed ID: 39199390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
    Juarez JG; Harun N; Thien M; Welschinger R; Baraz R; Pena AD; Pitson SM; Rettig M; DiPersio JF; Bradstock KF; Bendall LJ
    Blood; 2012 Jan; 119(3):707-16. PubMed ID: 22049516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.
    Gazitt Y; Akay C
    Stem Cells; 2004; 22(1):65-73. PubMed ID: 14688392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization and homing of hematopoietic stem cells.
    Suárez-Álvarez B; López-Vázquez A; López-Larrea C
    Adv Exp Med Biol; 2012; 741():152-70. PubMed ID: 22457109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New agents for mobilizing peripheral blood stem cells.
    Greinix HT; Worel N
    Transfus Apher Sci; 2009 Aug; 41(1):67-71. PubMed ID: 19615944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hematopoietic stem cells mobilization: state of the art in 2011 and perspectives].
    Bijou F; Ivanovic Z; Boiron JM; Nicolini F
    Transfus Clin Biol; 2011 Dec; 18(5-6):503-15. PubMed ID: 22019608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer.
    Selleri C; Montuori N; Ricci P; Visconte V; Baiano A; Carriero MV; Rotoli B; Rossi G; Ragno P
    Cancer Res; 2006 Nov; 66(22):10885-90. PubMed ID: 17108125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the mobilization of peripheral blood stem cells.
    Gazitt Y
    Curr Opin Hematol; 2002 May; 9(3):190-8. PubMed ID: 11953663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of the SDF-1-CXCR4 axis in hematopoiesis and the mobilization of hematopoietic stem cells to peripheral blood].
    Gieryng A; Bogunia-Kubik K
    Postepy Hig Med Dosw (Online); 2007 Jun; 61():369-83. PubMed ID: 17572657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in integrin expression are associated with altered homing properties of Lin(-/lo)Thy1.1(lo)Sca-1(+)c-kit(+) hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor.
    Wagers AJ; Allsopp RC; Weissman IL
    Exp Hematol; 2002 Feb; 30(2):176-85. PubMed ID: 11823053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell mobilization.
    Lemoli RM; D'Addio A
    Haematologica; 2008 Mar; 93(3):321-4. PubMed ID: 18310535
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies.
    Szmigielska-Kaplon A; Szemraj J; Hamara K; Robak M; Wolska A; Pluta A; Czemerska M; Krawczynska A; Jamroziak K; Szmigielska K; Robak T; Wierzbowska A
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):986-91. PubMed ID: 24680978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New agents in HSC mobilization.
    Domingues MJ; Nilsson SK; Cao B
    Int J Hematol; 2017 Feb; 105(2):141-152. PubMed ID: 27905003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plerixafor: a peripheral blood stem cell mobilizer.
    Kessans MR; Gatesman ML; Kockler DR
    Pharmacotherapy; 2010 May; 30(5):485-92. PubMed ID: 20411999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
    Uy GL; Rettig MP; Cashen AF
    Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
    Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
    Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
    J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells.
    Flomenberg N; DiPersio J; Calandra G
    Acta Haematol; 2005; 114(4):198-205. PubMed ID: 16269859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.